MarketWatch: Brazilian Tuberculosis Research Network to Evaluate PharmaJet(R) Needle-free Tropis(R) ID Injection Device as Delivery System for Tuberculin Skin Test Brazilian Tuberculosis Research Network to Evaluate PharmaJet(R) Needle-free Tropis(R) ID Injection Device as Delivery System for Tuberculin Skin Test A new skin test for tuberculosis infection has proven safe, easy to administer and accurate in two Phase III clinical trials, according to research presented at the ATS 2016 International Conference. Yahoo Finance: Brazilian Tuberculosis Research Network to Evaluate PharmaJet® Needle-free Tropis® ID Injection Device as Delivery System for Tuberculin Skin Test Brazilian Tuberculosis Research Network to Evaluate PharmaJet® Needle-free Tropis® ID Injection Device as Delivery System for Tuberculin Skin Test While tuberculosis spread is not significant nationally, lack of awareness of the latent form of the condition raises legitimate concerns for potential future infections. PharmaJet (R) , a company focused on improving the performance and outcomes of injectables through needle-free injection technology, announced that its partner, Brazilian Tuberculosis Research Network ...

Understanding the Context

News Medical: New skin test for TB infection proves safe, effective in clinical trials